Foretinib demonstrates anti-tumor activity and improves overall survival in preclinical models of hepatocellular carcinoma

被引：0
|
作者：
Hung Huynh
Richard Ong
Khee Chee Soo
机构：
[1] National Cancer Centre,Laboratory of Molecular Endocrinology, Division of Molecular and Cellular Research
来源：
Angiogenesis | 2012年 / 15卷
关键词：
Foretinib; HCC; Growth inhibition; Angiogenesis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：59 / 70
页数：11
相关论文
共 50 条
  • [21] SUMOylation inhibitors activate anti-tumor immunity by reshaping the immune microenvironment in a preclinical model of hepatocellular carcinoma
    Zengbin Wang
    Banglun Pan
    Lili Su
    Huahui Yu
    Xiaoxuan Wu
    Yuxin Yao
    Xiaoxia Zhang
    Jiacheng Qiu
    Nanhong Tang
    Cellular Oncology, 2024, 47 : 513 - 532
  • [22] MLN8054, an Aurora A Kinase inhibitor, demonstrates potent anti-tumor activity in disseminated tumor models
    Zhang, M.
    Meetze, M.
    Huck, J.
    Silva, M.
    Sells, T.
    Claiborne, C.
    Manfredi, M.
    EJC SUPPLEMENTS, 2006, 4 (12): : 113 - 113
  • [23] Selinexor (KPT-330) demonstrates anti-tumor efficacy in preclinical models of triple-negative breast cancer
    Arango, Natalia Paez
    Yuca, Erkan
    Zhao, Ming
    Evans, Kurt W.
    Scott, Stephen
    Kim, Charissa
    Gonzalez-Angulo, Ana Maria
    Janku, Filip
    Ueno, Naoto T.
    Tripathy, Debu
    Akcakanat, Argun
    Naing, Aung
    Meric-Bernstam, Funda
    BREAST CANCER RESEARCH, 2017, 19
  • [24] Selinexor (KPT-330) demonstrates anti-tumor efficacy in preclinical models of triple-negative breast cancer
    Natalia Paez Arango
    Erkan Yuca
    Ming Zhao
    Kurt W. Evans
    Stephen Scott
    Charissa Kim
    Ana Maria Gonzalez-Angulo
    Filip Janku
    Naoto T. Ueno
    Debu Tripathy
    Argun Akcakanat
    Aung Naing
    Funda Meric-Bernstam
    Breast Cancer Research, 19
  • [25] AZD6244 enhances the anti-tumor activity of sorafenib in ectopic and orthotopic models of human hepatocellular carcinoma (HCC)
    Huynh, Hung
    Ngo, Van Chanh
    Koong, Heng Nung
    Poon, Donald
    Choo, Su Pin
    Toh, Han Chong
    Thng, Choon Hua
    Chow, Pierce
    Ong, Hock Soo
    Chung, Alexander
    Goh, Boon Cher
    Smith, Paul D.
    Soo, Khee Chee
    JOURNAL OF HEPATOLOGY, 2010, 52 (01) : 79 - 87
  • [26] Anti-tumor activity of cisplatin is enhanced by PD-1 blockade in preclinical models of head and neck squamous cell carcinoma
    Tran, Linda
    Allen, Clint T.
    Park, So-Jin
    Xiao, Roy
    Van Waes, Carter
    Schmitt, Nicole C.
    CANCER RESEARCH, 2017, 77
  • [27] Anti-tumor activity of KNTC2 siRNA in orthotopic tumor model mice of hepatocellular carcinoma
    Makita, Yukimasa
    Murata, Shumpei
    Katou, Yoshiki
    Kikuchi, Kuniko
    Uejima, Hiroshi
    Teratani, Mika
    Hoashi, Yasutaka
    Kenjo, Eriya
    Matsumoto, Satoru
    Nogami, Masahiro
    Otake, Kentaro
    Kawamata, Yuji
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2017, 493 (01) : 800 - 806
  • [28] Anti-tumor activity and mechanism of oligoclonal hepatocellular carcinoma tumor-infiltrating lymphocytes in vivo and in vitro
    Wang, Wen-Chao
    Zhang, Zong-Qin
    Li, Peng-Peng
    Ma, Jun-Yong
    Chen, Lei
    Qian, Hai-Hua
    Shi, Le-Hua
    Yin, Zheng-Feng
    Sun, Bin
    Zhang, Xiao-Feng
    CANCER BIOLOGY & THERAPY, 2019, 20 (09) : 1187 - 1194
  • [29] Anti-tumor activity of Debio 0123 in combination with sacituzumab govitecan in preclinical models of breast cancer
    Piggott, Luke
    Imedio, Esteban Rodrigo
    Staehli, Francesco
    CANCER RESEARCH, 2024, 84 (06)
  • [30] Dual immune checkpoint inhibition enhances the anti-tumor activity of trastuzumab deruxtecan in preclinical models
    Jenkins, Liam
    Kazlauskas, Laura
    Wilson, Matt
    Hammond, Scott A.
    Proia, Theresa
    Mettetal, Jerome
    CANCER RESEARCH, 2024, 84 (06)
12345